NMDA receptors as targets for drug action in neuropathic pain. (Q34430622)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11698028%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

review article

1 reference

title

NMDA receptors as targets for drug action in neuropathic pain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11698028%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

0 references

Christopher G. Parsons

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11698028%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

Parsons CG

series ordinal

1

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11698028%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11698028%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11698028%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11698028%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

71-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11698028%20AND%20SRC:MED&resulttype=core&format=json

The effect of Ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin--a double-blind, placebo-controlled, human experimental study

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Long-term depression of excitatory synaptic transmission and its relationship to long-term potentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Synaptic plasticity: LTP and LTD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Effects of short-acting NMDA receptor antagonist MRZ 2/576 on morphine tolerance development in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Short-acting NMDA receptor antagonist MRZ 2/576 produces prolonged suppression of morphine withdrawal in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Drugs acting at the strychnine-insensitive glycine receptor do not induce HSP-70 protein in the cingulate cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Inflammation-induced changes in peripheral glutamate receptor populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Evidence for the interaction of glutamate and NK1 receptors in the periphery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The N-methyl-D-aspartate antagonistic and opioid components of d-methadone antinociception in the rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Evidence for an inflammation-induced change in the local glutamatergic regulation of postganglionic sympathetic efferents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Memories of NMDA receptors and LTP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

A cure for wind up: NMDA receptor antagonists as potential analgesics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The NMDA antagonist Memantine blocks pain behavior in a rat model of formalin-induced facial pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The effects of the clinically tested NMDA receptor antagonist memantine on carrageenan-induced thermal hyperalgesia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

N-Methyl-D-aspartate attenuates opioid receptor-mediated G protein activation and this process involves protein kinase C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Antihyperalgesic effect of the N-methyl-D-aspartate receptor antagonist dextromethorphan in the oral surgery model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Different threshold levels of postsynaptic [Ca2+]i have to be reached to induce LTP and LTD in neocortical pyramidal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Wind-up of spinal cord neurones and pain sensation: much ado about something?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The use of NMDA-receptor antagonists in the treatment of chronic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Mrz 2/579, a fast kinetic NMDA channel blocker, reduces the development of morphine tolerance in awake rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Excitability changes of somatic and viscero-somatic nociceptive reflexes in the decerebrate-spinal rabbit: role of NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Effects of a partial agonist and a full antagonist acting at the glycine site of the NMDA receptor on inflammation-induced mechanical hyperalgesia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Synaptic plasticity in the hippocampus: LTP and LTD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The effect of naloxone on ketamine-induced effects on hyperalgesia and ketamine-induced side effects in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Chemically-diverse ligands at the glycine B site coupled to N-methyl-D-aspartate (NMDA) receptors selectively block the late phase of formalin-induced pain in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Formalin-induced release of excitatory amino acids in the skin of the rat hindpaw.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Glutamate in CNS disorders as a target for drug development: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Wind-up and the NMDA receptor: from animal studies to humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Induction of long-term potentiation at spinal synapses by noxious stimulation or nerve injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Low-affinity NMDA receptor channel blockers inhibit acquisition of intravenous morphine self-administration in naive mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901307-3

10.1016/S0014-2999(01)01307-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11698028%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference